The cost of Trulicity (dulaglutide) when covered by insurance can vary significantly depending on the specific insurance plan. Factors such as the deductible, copay, coinsurance, and whether Trulicity is on the plan's formulary all play a role in determining the out-of-pocket expense.
How much does Trulicity cost without insurance?
Without insurance, the retail price for a 30-day supply of Trulicity can range from approximately $1,000 to $1,200 or more [1]. This price reflects the full cost of the medication before any discounts or insurance coverage.
What assistance programs are available for Trulicity?
Eli Lilly, the manufacturer of Trulicity, offers patient assistance programs designed to help reduce the cost for eligible individuals. The Trulicity Savings Card can provide eligible commercially insured patients with savings of up to $130 per monthly prescription [1]. For uninsured patients or those facing high out-of-pocket costs, Lilly Cares Foundation provides free medication to qualifying low-income uninsured individuals [1].
How does insurance affect Trulicity pricing?
When Trulicity is covered by insurance, the cost to the patient is typically a fixed copay or a percentage of the drug's cost (coinsurance), after any deductible has been met. Many insurance plans have tiered formularies where drugs like Trulicity might fall into a higher tier, potentially resulting in a higher copay compared to lower-tier medications. It is advisable to check with one's specific insurance provider or review the plan's formulary for precise cost details.
What is the typical copay for Trulicity with insurance?
Copay amounts for Trulicity with insurance can range widely. Some plans may offer copays as low as $10 or $25 per month for eligible patients using the manufacturer's savings card. However, without such savings cards or for plans with higher copay tiers, the cost could be considerably more, potentially reaching $100 or more per month.
When does Trulicity's patent expire?
The patent landscape for Trulicity is complex and involves multiple patents covering different aspects of the drug. Information from DrugPatentWatch.com indicates that key patents related to Trulicity have expiration dates extending into the future, with some expiring around 2027 and others later [2]. The exact expiration of market exclusivity can be influenced by various factors, including patent litigation and regulatory exclusivities.
Can generic versions of Trulicity be available?
The availability of generic versions of Trulicity is contingent upon the expiration of its patents and any associated exclusivities. As of now, Trulicity is still under patent protection, and generic versions are not yet available. Once patents expire, generic manufacturers can apply to the U.S. Food and Drug Administration (FDA) for approval to market their own versions, which are typically less expensive.
What are the alternatives to Trulicity?
Trulicity belongs to a class of medications called GLP-1 receptor agonists, used to manage type 2 diabetes. Other medications in this class include semaglutide (Ozempic, Rybelsus, Wegovy), liraglutide (Victoza, Saxenda), and exenatide (Byetta, Bydureon). The choice of medication depends on individual patient needs, medical history, and physician recommendations.
Sources:
[1] https://www.trulicity.com/financial-assistance
[2] https://www.drugpatentwatch.com/drug/trulicity/dulaglutide